<DOC>
	<DOCNO>NCT00003278</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Combining radiation therapy corticosteroid , dexamethasone , may effective treatment non-Hodgkin 's lymphoma . PURPOSE : Phase II trial study effectiveness radiation therapy high-dose dexamethasone treat old patient primary CNS non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Radiation Therapy High-Dose Corticosteroids Treating Older Patients With Primary CNS Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - Assess effectiveness high-dose dexamethasone whole-brain radiotherapy maintain response prevent recurrence elderly patient primary central nervous system non-Hodgkin 's lymphoma . - Assess toxic effect regimen patient . - Assess survival rate patient regimen . - Identify anatomic rate recurrence frequency systemic involvement patient treat regimen . - Identify factor appear associate outcome patient treat regimen . OUTLINE : Patients undergo whole-brain radiotherapy ( WBRT ) daily 5 day week 4.5 week . Beginning 30 day WBRT complete , patient receive high-dose dexamethasone IV day 1-5 course 1 day 1 subsequent course . Courses repeat every 28 day absence disease progression unacceptable toxicity . Patients follow 1 month radiotherapy , every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 28 patient accrue study within 6 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Pathologically confirm nonHodgkin 's lymphoma intracranial lesion Intraocular lymphoma eligible , sole site disease No occult systemic lymphoma Measurable evaluable disease CT scan MRI No neoplastic meningitis gross spinal cord involvement PATIENT CHARACTERISTICS : Age : 70 Performance status : ECOG 03 Other : No prior history lymphoma No active malignancy except basal cell skin cancer carcinoma situ cervix HIV negative No active peptic ulcer disease No uncontrolled diabetes mellitus No active pancreatitis No active bleeding No poorly control major psychiatric illness No serious uncontrolled infection PRIOR CONCURRENT THERAPY : Biologic therapy : No prior bone marrow transplantation Chemotherapy : No prior chemotherapy Radiotherapy : No prior radiotherapy brain head neck region Surgery : No prior transplantation ( renal , hepatic , cardiac )</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>primary central nervous system non-Hodgkin lymphoma</keyword>
	<keyword>intraocular lymphoma</keyword>
</DOC>